Haruyasu Murakami

Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial.

M. Satouchi, Y. Fujisaka, Y. Okuma, 2024, Lung cancer.

Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study.

T. Tokito, H. Horinouchi, S. Atagi, 2024, Thoracic cancer.